BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1125 related articles for article (PubMed ID: 12814430)

  • 1. The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer.
    Vermeulen K; Van Bockstaele DR; Berneman ZN
    Cell Prolif; 2003 Jun; 36(3):131-49. PubMed ID: 12814430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel small molecule cyclin-dependent kinases modulators in human clinical trials.
    Senderowicz AM
    Cancer Biol Ther; 2003; 2(4 Suppl 1):S84-95. PubMed ID: 14508085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell cycle control as a basis for cancer drug development (Review).
    McDonald ER; El-Deiry WS
    Int J Oncol; 2000 May; 16(5):871-86. PubMed ID: 10762622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting Cyclin-Dependent Kinases and Cell Cycle Progression in Human Cancers.
    Santo L; Siu KT; Raje N
    Semin Oncol; 2015 Dec; 42(6):788-800. PubMed ID: 26615126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early development of cyclin dependent kinase modulators.
    Roy KK; Sausville EA
    Curr Pharm Des; 2001 Nov; 7(16):1669-87. PubMed ID: 11562305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclins and related kinases in cancer cells.
    Malumbres M
    J BUON; 2007 Sep; 12 Suppl 1():S45-52. PubMed ID: 17935277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel direct and indirect cyclin-dependent kinase modulators for the prevention and treatment of human neoplasms.
    Senderowicz AM
    Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S61-73. PubMed ID: 12819936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small-molecule cyclin-dependent kinase modulators.
    Senderowicz AM
    Oncogene; 2003 Sep; 22(42):6609-20. PubMed ID: 14528286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting cyclins and cyclin-dependent kinases in cancer: lessons from mice, hopes for therapeutic applications in human.
    Lee YM; Sicinski P
    Cell Cycle; 2006 Sep; 5(18):2110-4. PubMed ID: 16969111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of cyclin-dependent kinase inhibitors alone or in combination with established cytotoxic drugs in cancer chemotherapy.
    Grant S; Roberts JD
    Drug Resist Updat; 2003 Feb; 6(1):15-26. PubMed ID: 12654284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclins and CDKS in development and cancer: lessons from genetically modified mice.
    Santamaria D; Ortega S
    Front Biosci; 2006 Jan; 11():1164-88. PubMed ID: 16146805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CDK inhibitors in clinical development for the treatment of cancer.
    Fischer PM; Gianella-Borradori A
    Expert Opin Investig Drugs; 2003 Jun; 12(6):955-70. PubMed ID: 12783600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin-dependent kinase modulators: a novel class of cell cycle regulators for cancer therapy.
    Senderowicz AM
    Cancer Chemother Biol Response Modif; 2001; 19():165-88. PubMed ID: 11686013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclin-dependent kinase modulators and cancer therapy.
    Gallorini M; Cataldi A; di Giacomo V
    BioDrugs; 2012 Dec; 26(6):377-91. PubMed ID: 22928661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin-dependent kinase inhibitors: novel anticancer agents.
    Mani S; Wang C; Wu K; Francis R; Pestell R
    Expert Opin Investig Drugs; 2000 Aug; 9(8):1849-70. PubMed ID: 11060782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclin-dependent kinases as new targets for the prevention and treatment of cancer.
    Senderowicz AM
    Hematol Oncol Clin North Am; 2002 Oct; 16(5):1229-53. PubMed ID: 12512390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The history and future of targeting cyclin-dependent kinases in cancer therapy.
    Asghar U; Witkiewicz AK; Turner NC; Knudsen ES
    Nat Rev Drug Discov; 2015 Feb; 14(2):130-46. PubMed ID: 25633797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin-Dependent Kinases (CDK) and Their Role in Diseases Development-Review.
    Łukasik P; Załuski M; Gutowska I
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances and new directions in the discovery and development of cyclin-dependent kinase inhibitors.
    Fischer PM
    Curr Opin Drug Discov Devel; 2001 Sep; 4(5):623-34. PubMed ID: 12825457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revisiting the "Cdk-centric" view of the mammalian cell cycle.
    Malumbres M
    Cell Cycle; 2005 Feb; 4(2):206-10. PubMed ID: 15655365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.